Serum proteomic analysis revealed diagnostic value of hemoglobin for nonalcoholic fatty liver disease

Journal of Hepatology

Volumn 56, Issue 1, 2012, Pages 241-247

  Yu, Chaohui ^a   Xu, Chengfu ^a   Xu, Lei ^a   Yu, Jiekai ^a   Miao, Min ^b   Li, Youming ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Zhenhai Lianhua Hospital   (China)

Author keywords

Biomarker; Hemoglobin; Nonalcoholic fatty liver disease

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN; PROTEIN;

ARTICLE; BIOINFORMATICS; BLOOD SAMPLING; BODY MASS; DIAGNOSTIC VALUE; ENZYME INDUCTION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEOME; PROTEOMICS; RISK FACTORS;

EID: 83555164850     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.05.027     Document Type: Article

References (36)

1. S. Jimba, T. Nakagami, M. Takahashi, T. Wakamatsu, Y. Hirota, and Y. Iwamoto Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults Diabet Med 22 2005 1141 1145 (Pubitemid 41224170)
2. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD single topic conference Hepatology 37 2003 1202 1219 (Pubitemid 36538699)
3. J.G. Fan, J. Zhu, X.J. Li, L. Chen, L. Li, and F. Dai Prevalence of and risk factors for fatty liver in a general population of Shanghai, China J Hepatol 43 2005 508 514 (Pubitemid 41111434)
4. D.N. Amarapurkar, E. Hashimoto, L.A. Lesmana, J.D. Sollano, P.J. Chen, and K.L. Goh How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences J Gastroenterol Hepatol 22 2007 788 793 (Pubitemid 46911047)
5. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, and M. Lenzi Nonalcoholic fatty liver disease: a feature of the metabolic syndrome Diabetes 50 2001 1844 1850 (Pubitemid 33641605)
6. G. Marchesini, E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, and R. Manini Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome Hepatology 37 2003 917 923 (Pubitemid 36397405)
7. M.K. Oh, J. Winn, and F. Poordad Review article: diagnosis and treatment of non-alcoholic fatty liver disease Aliment Pharmacol Ther 28 2008 503 522
8. A. Wieckowska, and A.E. Feldstein Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive Semin Liver Dis 28 2008 386 395
9. P. Angulo Nonalcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
10. N.A. Shackel, and G.W. McCaughan Liver biopsy: is it still relevant Intern Med J 36 2006 689 691
11. E. Emanuele Is biopsy always necessary? Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity Hepatology 48 2008 2086 2087
12. D.G. Ward, N. Suggett, Y. Cheng, W. Wei, H. Johnson, and L.J. Billingham Identification of serum biomarkers for colon cancer by proteomic analysis Br J Cancer 94 2006 1898 1905 (Pubitemid 43882582)
13. K. Chapman The ProteinChip Biomarker System from Ciphergen Biosystems: a novel proteomics platform for rapid biomarker discovery and validation Biochem Soc Trans 30 2002 82 87
14. J.X. Wang, J.K. Yu, L. Wang, Q.L. Liu, J. Zhang, and S. Zheng Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma Proteomics 6 2006 5344 5349 (Pubitemid 44547171)
15. Y.D. Chen, S. Zheng, J.K. Yu, and X. Hu Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population Clin Cancer Res 10 2004 8380 8385 (Pubitemid 40053400)
16. V. Trak-Smayra, D. Dargere, R. Noun, M. Albuquerque, C. Yaghi, and M.H. Gannage-Yared Serum proteomic profiling of obese patients: correlation with pathology and evolution after bariatric surgery Gut 58 2009 825 832
17. M.D. Zeng, J.G. Fan, L.G. Lu, Y.M. Li, C.W. Chen, and B.Y. Wang Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases J Dig Dis 9 2008 108 112 (Pubitemid 351566633)
18. Y. Li, C. Xu, C. Yu, L. Xu, and M. Miao Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study J Hepatol 50 2009 1029 1034
19. E.M. Brunt, C.G. Janney, B.A.M. Di, B.A. Neuschwander-Tetri, and B.R. Bacon Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 1999 2467 2474 (Pubitemid 29420675)
20. L.A. Adams, S. Sanderson, K.D. Lindor, and P. Angulo The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies J Hepatol 42 2005 132 138 (Pubitemid 40038911)
21. C. Xu, C. Yu, L. Xu, M. Miao, and Y. Li High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study PLoS One 5 2010 e11578
22. P.M. Grambsch, and T.M. Therneau Proportional hazards tests and diagnostics based on weighted residuals Biometrika 81 1994 515 526
23. Y. Yilmaz, E. Ulukaya, and E. Dolar Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels Hepatology 49 2009 697
24. R. Pieper, C.L. Gatlin, A.J. Makusky, P.S. Russo, C.R. Schatz, and S.S. Miller The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins Proteomics 3 2003 1345 1364 (Pubitemid 36929557)
25. C. Rosty, L. Christa, S. Kuzdzal, W.M. Baldwin, M.L. Zahurak, and F. Carnot Identification of hepatocarcinoma-intestine-pancreas/pancreatitis- associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology Cancer Res 62 2002 1868 1875 (Pubitemid 34408515)
26. Z.M. Younossi, M. Jarrar, C. Nugent, M. Randhawa, M. Afendy, and M. Stepanova A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH) Obes Surg 18 2008 1430 1437
27. Y. Yilmaz, and E. Dolar Biomarkers for noninvasive biochemical diagnosis of nonalcoholic steatohepatitis: tools or decorations World J Gastroenterol 15 2009 4346 4347
28. B. Buttari, E. Profumo, L. Petrone, D. Pietraforte, A. Siracusano, and P. Margutti Free hemoglobin: a dangerous signal for the immune system in patients with carotid atherosclerosis Ann NY Acad Sci 1107 2007 42 50 (Pubitemid 47528780)
29. R.P. Rother, L. Bell, P. Hillmen, and M.T. Gladwin The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease JAMA 293 2005 1653 1662 (Pubitemid 40471796)
30. P. Huang, L.H. Lo, Y.C. Chen, R.T. Lin, J. Shiea, and C.K. Liu Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke J Neurol 256 2009 625 631
31. L. Xu, C.F. Xu, C.H. Yu, M. Miao, and Y.M. Li Haemoglobin and non-alcoholic fatty liver disease: further evidence from a population-based study Gut 58 2009 1706 1707
32. M. Takeuchi, K. Okamoto, T. Takagi, and H. Ishii Ethnic difference in inter-East Asian subjects with normal glucose tolerance and impaired glucose regulation: a systematic review and meta-analysis focusing on fasting serum insulin Diabetes Res Clin Pract 82 2008 383 390
33. T. Nakagawa, Y. Muramoto, M. Hori, S. Mihara, T. Marubayashi, and K. Nakagawa A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease Clin Chim Acta 398 2008 34 38
34. A.J. Hanley, A.J. Karter, A. Festa, R. D'Agostino Jr., L.E. Wagenknecht, and P. Savage Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study Diabetes 51 2002 2642 2647 (Pubitemid 34827418)
35. H.E. Resnick, K. Jones, G. Ruotolo, A.K. Jain, J. Henderson, and W. Lu Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study Diabetes Care 26 2003 861 867 (Pubitemid 36929356)
36. J. Jeppesen, T.W. Hansen, S. Rasmussen, H. Ibsen, C. Torp-Pedersen, and S. Madsbad Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study J Am Coll Cardiol 49 2007 2112 2119 (Pubitemid 46771048)